摘要
目的分析阿托伐他汀在冠心病治疗中的抗炎作用。方法收取我院70例冠心病患者,收取时间在2015年4月—2017年1月,将患者随机分为两组,对照组患者实施常规方式治疗,观察组患者实施阿托伐他汀治疗。结果观察组冠心病患者实施治疗后并发症发生率、血清总胆固醇(3.30±0.45)mmol/L、低密度脂蛋白胆固醇(2.75±0.29)mmol/L、高密度脂蛋白胆固醇(1.65±0.65)mmol/L、C反应蛋白水平(1.70±0.41)mmol/L、甘油三酯(100.12±1.03)mmol/L优于对照组(P<0.05)。结论阿托伐他汀在冠心病治疗中具有显著的抗炎作用,能促进患者康复。
Objective To analyze the anti-inflammatory effect of atorvastatin in the treatment of coronary heart disease. Methods 70 patients with coronary heart disease in our hospital from April 2015 to January 2017 were randomly divided into 2 groups, the control group received routine treatment, the observation group was treated with atorvastatin. Results In observation group, after treatment, complication rate, serum total cholesterol(3.30±0.45) mmol/L, low density lipoprotein cholesterol(2.75±0.29) mmol/L, high density lipoprotein cholesterol(1.65±0.65) mmol/L, C reactive protein level(1.70±0.41) mmol/L, triglyceride(100.12±1.03) mmol/L were better than the control group(P〈0.05). Conclusion Atorvastatin in the treatment of coronary heart disease has significant anti-inflammatory effect, can promote the rehabilitation of patients.
出处
《中国继续医学教育》
2017年第18期151-153,共3页
China Continuing Medical Education
关键词
阿托伐他汀
冠心病
抗炎
atorvastatin
coronary heart disease
anti inflammation triglyceride